551
Views
16
CrossRef citations to date
0
Altmetric
Antimicrobial Original Research Paper

Ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections

, , , , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mazen S. Bader, Mark Loeb, Daniela Leto & Annie A. Brooks. (2020) Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. Postgraduate Medicine 132:3, pages 234-250.
Read now
Mazen S Bader, Mark Loeb & Annie A Brooks. (2017) An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgraduate Medicine 129:2, pages 242-258.
Read now

Articles from other publishers (14)

L. E. Belyi. (2023) Prospects of oral fosfomycin for the treatment of chronic bacterial prostatitis. Andrology and Genital Surgery 24:3, pages 42-49.
Crossref
Jonas Tverring, Emeli Månsson, Vigith Andrews & Oskar Ljungquist. (2023) Pivmecillinam with Amoxicillin/Clavulanic acid as step down oral therapy in febrile Urinary Tract Infections caused by ESBL-producing Enterobacterales (PACUTI). Trials 24:1.
Crossref
Carlos Ernesto Lombo Moreno, Oscar Mauricio Muñoz Velandia & Allan Enrico Solano. (2023) Costos de atención domiciliaria de nivel hospitalario vs atención intrahospitalaria en infección de vías urinarias complicada. Gerencia y Políticas de Salud 22.
Crossref
Arzu Nazli Zeka, Vildan Avkan‐Oguz, Caglar Irmak, Oya Eren Kutsoylu, Sema Alp Cavus, Ziya Kuruüzüm & M. Cem Ergon. (2021) Daily inpatient ertapenem therapy can be an alternative to hospitalization for the treatment of complicated urinary tract infections during the COVID‐19 pandemic. International Journal of Clinical Practice 75:7.
Crossref
Jolene OON Ee Ling, Brenda SALADA, LIM Yin Shan, Sophia ARCHULETA & Dale FISHER. (2021) Safety and Efficacy of a 5-Minute Infusion versus the Standard 30-minute Infusion for Antibiotics in an Outpatient Setting. International Journal of Infectious Diseases.
Crossref
Julie Poline, Martine Postaire, Perrine Parize, Benoit Pilmis, Emmanuelle Bille, Jean Ralph Zahar, Pierre Frange, Jérémie F. Cohen, Olivier Lortholary & Julie Toubiana. (2021) Stewardship program on carbapenem prescriptions in a tertiary hospital for adults and children in France: a cohort study. European Journal of Clinical Microbiology & Infectious Diseases 40:5, pages 1039-1048.
Crossref
Donald J. AbrahamSebastian A. Testero, Leticia I. Llarrull, Jed F. Fisher & Shahriar Mobashery. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 1 188 .
Doug L. Fink, Steven Collins, Ronnie Barret, Gabriele Pollara, Michael Marks & Sarah Logan. (2019) Shortening duration of ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections: A retrospective study. PLOS ONE 14:9, pages e0223130.
Crossref
Ilias Karaiskos, Lambrini Galani, Vissaria Sakka, Aikaterini Gkoufa, Odysseas Sopilidis, Dimitrios Chalikopoulos, Gerasimos Alivizatos & Eleni Giamarellou. (2019) Oral fosfomycin for the treatment of chronic bacterial prostatitis. Journal of Antimicrobial Chemotherapy 74:5, pages 1430-1437.
Crossref
Liang En Wee, Mangaikarasi Sundarajoo, Way-Fang Quah, Ahmad Farhati, Jie-ying Huang & Ying-Ying Chua. (2018) Sociodemographic and clinical factors associated with acceptance of outpatient parenteral antibiotic therapy in a Singapore tertiary hospital from 2014 to 2017. European Journal of Clinical Microbiology & Infectious Diseases 38:2, pages 277-284.
Crossref
Pedro Sanroma, Pedro Muñoz, Manuel Mirón-Rubio, Ana Aguilera, Oriol Estrada, Dora García, Víctor J González-Ramallo, Marcos Pajarón, Giusi A Sgaramella, Carmen R González, Abel Mujal, Aquilino Abad, Anna Solé, Soledad González, Carmen Escalada, Isabel Vitoria, María J Gómez, Juan J Parra, Isabel Sampedro & Iliana Pereda. (2018) Effectiveness and safety of ertapenem used in hospital-at-home units: data from Spanish Outpatient Parenteral Antimicrobial Therapy Registry. Future Microbiology 13:12, pages 1363-1373.
Crossref
Marianne Bollestad, Nils Grude, Sigrid Solhaug, Niclas Raffelsberger, Nina Handal, Hans-Johnny Schjelderup Nilsen, Monica Regine Romstad, Andreas Emmert, Yngvar Tveten, Arne Søraas, Pål A Jenum, Synne Jenum, Janne Møller-Stray, Einar Tollaksen Weme, Morten Lindbaek & Gunnar Skov Simonsen. (2018) Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL-producing Escherichia coli: a prospective, multicentre, observational cohort study. Journal of Antimicrobial Chemotherapy 73:9, pages 2503-2509.
Crossref
Jesús Rodríguez-Baño, Belén Gutiérrez-Gutiérrez, Isabel Machuca & Alvaro Pascual. (2018) Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae. Clinical Microbiology Reviews 31:2.
Crossref
. (2017) Ertapenem. Reactions Weekly 1643:1, pages 115-115.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.